US FDA sets 30 June deadline for finalising companion Dx guidance
This article was originally published in Clinica
Executive Summary
The US FDA's guideline on the development of companion diagnostics is expected to be finalised by 30 June, the agency has announced in a document outlining its medical device unit's strategic priorities for 2012.